EMBRAVE: image-guided brachytherapy for vaginal cancer
The international EMBRAVE study aims to improve clinical outcomes for vaginal cancer patients treated with radio(chemo)therapy and image-guided brachytherapy.
GlIOscreen offers a platform for the customized screening of new anti-cancer agents in clinically relevant patient-derived glioma samples and identifies predictive markers for treatment response.
We aim to optimize the clinical management of neurogenic and non-neurogenic bladder dysfunction, including urinary incontinence and retention, in paediatric and adult patients.
